A strategic, visionary leader, Ms. Klinger is driven by a deep personal and professional desire to meaningfully contribute to making the world a better place than she found it. As a breast cancer survivor, she has experienced first-hand the critical importance of creating sustainable health care systems capable of providing the right treatment for the right patient at the right time.
Ms. Klinger joined Moderna as chief legal officer on June 1, 2021. Most recently, she was chief legal officer at Novartis. Previously, she served as chief ethics, risk & compliance officer from April to May 2018, and was appointed to the Executive Committee of Novartis in this role. Before that, she was chief ethics and compliance officer and global head of litigation from 2016 to 2018. She joined Novartis in 2011 as general counsel for North America at Sandoz Inc., and later served as general counsel and global head of legal at Sandoz International from 2012 to 2016. Prior to Novartis, Ms. Klinger was a partner at Mayer Brown from 2010 to 2011, and general counsel and senior vice president at Solvay Pharmaceuticals from 2008 to 2010.
Ms. Klinger holds a juris doctor with honors from The University of North Carolina at Chapel Hill and a bachelor’s degree in psychology from the University of Notre Dame. She is a member of the State Bar of Georgia and of the District of Columbia Bar.